References
- Golan A, Ron-el R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989;44:430–40
- Kol S, Itskovitz-Eldor J. Severe OHSS: yes, there is a strategy to prevent it Hum Reprod 2000;15: 2266–7
- Whelam III JG, Vlahos NF. The ovarian hyper-stimulation syndrome. Fertil Steril 2000;5:883–96
- D'Ambrogio G, Fasciani A, Monti M, etal. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyper-stimulation syndrome. Gynecol Endocrinol 1999;13:311–15
- Loret de Mola JR, Goldfarb JM, Hecht BR, et al. Gonadotrophins induce higher active renin levels in the follicular fluid ofnormal and hyperstimulated cycles. Gynecol Endocrinol 1999;13:155–60
- Morris RS, Paulson RJ. Increased angiotensin-converting enzyme activity in a patient with severe ovarian hyperstimulation syndrome. Fertil Steril 1999;71:562–3
- Chen CD, Wu MY, Chen HF, et al. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. Hum Reprod 2000;15:66–71
- Abaoulghar MA, Mansour RT, Serour GI, et al. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 1999;87:81–5
- Pellicer A, Albert C, Mercader A, et al. The patho-genesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1 beta, interleukin-6 and vascular endothelial growth factor. Fertil Steril 1999;71:482–9
- Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 1997;12:1129–37
- Gustafion 0, Carlstrom K, Nylund L. Andro-stenedione as a predictor of ovarian hyperstimula-tion syndrome. Hum Reprod 1992;7:918–21
- Delvigne A, Demoulin A, Smitz J, et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I: Clini-cal and biological features. Hum Reprod 1993; 8:1353–60
- Enskog A, Henriksson M, Unander M, et al. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyper-stimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999;71:808–14
- Blankstein J, Shalev J, Saadon T, et al. Ovarian hyperstimulation syndrome: prediction by number and size ofpreovulatory ovarian follicles. Fertil Steril 1987;47:597–602
- Buyalos RP, Lee CT. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertil-ization. Fertil Steril 1996;65:1–10
- Dourroun NE, Williams DB. Prevention and treatment of ovarian hyperstimulation syndrome. Semin Reprod Endocrinol 1996;14:355–65
- Egbase PE, Sharhan MA, Grudzinskas JG, et al. Ethical issues on studies on the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 1999;14:2924–4
- Murdoch AP, Evbuomwan I, etal. Severe compli-cations of ovarian hyperstimulation syndrome are preventable. Hum Reprod 1999;14:2922–4